Natl. Insulin Summit Begins In Pondy
07 November, Puducherry
The two-day National Insulin Summit, conducted by Diabetes Research Society (Diabaid) and supported by Novo Nordisk, the world leader in diabetes care began here Saturday.
The 9th National Insulin Summit with congregation of more than 300 experts in the field of diabetes from across India saw discussions, deliberations and presentations on various aspects of diabetes and insulin management such asChanging paradigm in diabetes management:
Leading role of insulin therapy; a glimpse at the evolving concepts in diabetes, Improving compliance and outcome in the era of complex therapeutic regimens; and New and emerging Insulin therapies: Whats the future?,
Novel insights in diabetes managementand other topics on the matter,according to a release here today. Dr. Ashok Kumar Das, Professor of medicine and Prof and head of endocrinology, Pondicheey Institute of medical sciences and NIS National Convenor said, Indians are genetically predisposed towards diabetes.
A high carb diet, obesity due to life style changes and the impact of urbanization and globalization have led to a rapid rise of diabetes in India. In India almost 50% of people with diabetes remain undetected. Hence many patients have micro-vascular and macro-vascular complications present already at the time of diagnosis.
The focus of National Insulin Summit this year will be to discuss and share path breaking innovations to combat diabetes. I am hopeful that the medical professionals gathered here will leverage this opportunity to update themselves about the latest medical advances in diabetes therapy and insulin. The need of the hour is to join the fight against diabetes for a healthy India,he said.
According to Mr. Melvin Dsouza, VP and GM Novo Nordisk India Diabetes is is an emergency in slow motion. In India we have almost 68 million people with diabetes.
The disease not just complicates everyday living; it also puts the affected person at strong risk of complications. By partnering with healthcare providers, we can create a conducive environment and infrastructure for early detection, diagnosis and management and ensure improved outcome for people with diabetes. We are happy to support DIABAID in their initiative of creating a platform to ideate, debate and share scientific updates on diabetes